The CJEU’s decision on excluding specific in-vitro from the OGM regulation sparked contrasting reactions from multiple associations. The eight-year-long debate’s verdict comes as the EC works to define specific rules on NGTs, fueling the debate amongst NGOs.
Outside the UE, the US are expecting higher investments on the NTGs studies to boost up their competitivity, while Asia, Africa, and Latin America are starting to authorize the commercialization of GM products.
O artigo foi publicado originalmente em Farm Europe.